|
Market Closed -
London S.E.
01:20:00 11/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 323.90 CHF | 0.00% |
|
0.00% | -1.29% |
| 03/09 | Hutchmed Enters Licensing Agreement With GSK for Cancer Drug | DJ |
| 03/09 | Roche, Treeline Biosciences to Evaluate Combination Therapy for B-cell Lymphomas | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.11% | -3.16% | -8.84% | -1.18% | +4.50% | +48.82% | +91.49% | +368.89% | +1,335.33% | 1,002B | |
| -0.27% | -4.34% | +1.73% | +11.68% | +28.70% | +51.52% | +65.89% | +59.52% | +125.28% | 644B | |
| +1.63% | -2.00% | +2.84% | +13.36% | +11.60% | +20.49% | +71.12% | +139.03% | +302.46% | 443B | |
| -0.63% | -3.09% | -7.40% | +6.67% | +5.27% | +29.84% | +34.59% | +0.44% | +43.96% | 343B | |
| +0.43% | -14.61% | -11.56% | -5.80% | +2.32% | +11.32% | +27.26% | +42.54% | +44.88% | 262B | |
| +0.93% | -3.19% | -1.93% | -12.67% | -14.74% | -1.31% | +8.41% | +43.86% | +143.99% | 245B | |
| -2.25% | -13.88% | -8.32% | +13.25% | +16.85% | +37.33% | +47.43% | +78.93% | +129.64% | 212B | |
| -0.90% | -5.06% | -6.48% | +1.13% | -11.98% | -18.47% | -57.75% | -8.75% | +93.38% | 199B | |
| -0.58% | -4.24% | +8.83% | +19.20% | +17.98% | +25.65% | +90.54% | +103.99% | +85.53% | 181B | |
| -0.47% | -4.03% | +2.22% | +8.01% | +11.04% | +12.54% | -19.27% | -39.35% | -18.91% | 158B | |
| -1.26% | -7.78% | -1.78% | +18.10% | +13.50% | +32.43% | +50.00% | +172.87% | +449.27% | 132B | |
| -1.02% | -6.37% | -1.68% | +14.66% | +18.19% | +35.21% | +4.82% | +0.98% | +14.53% | 132B | |
| -0.90% | -3.54% | -2.59% | -3.21% | -11.06% | -8.36% | -26.68% | -10.14% | +4.58% | 103B | |
| -1.55% | -4.88% | -7.89% | -7.60% | -2.69% | +19.32% | +22.94% | +0.06% | -11.20% | 97.89B | |
| -0.72% | -6.23% | -11.30% | -14.22% | -22.70% | -4.12% | +42.33% | +50.00% | +458.13% | 69.38B | |
| -0.18% | -1.84% | +1.53% | +12.20% | +16.79% | +25.38% | +24.25% | +51.11% | +20.97% | 58.38B | |
| -1.14% | -1.30% | -1.08% | +37.69% | +31.59% | +73.74% | -2.97% | +6.39% | -48.75% | 56.24B | |
| -3.98% | -6.59% | -20.76% | -8.68% | -27.93% | -38.95% | +5.79% | -9.53% | +167.88% | 43.9B | |
| -1.36% | -0.74% | +0.58% | +8.25% | +16.47% | +85.74% | +277.86% | +295.54% | -27.60% | 42.94B | |
| Average | -0.72% | -4.69% | -3.89% | +5.83% | +5.46% | +23.06% | +39.90% | +70.86% | +174.39% | 232.83B | |
| Weighted average by Cap. | -0.16% | -4.43% | -3.79% | +5.14% | +8.26% | +29.87% | +50.10% | +126.62% | +400.21% |
- Stock Market
- Stocks
- ROP Stock
- 0QOK Stock
- Sector Roche Holding AG
Select your edition
All financial news and data tailored to specific country editions
